Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 653 of 6351
-
Stroke recovery breakthrough? new study tests simple blood flow trick
Disease control Recruiting nowAcute ischemic stroke (AIS) is the most common type of stroke, with high incidence rate and mortality. Endovascular therapy is currently the most effective treatment for AIS with large vessel occlusion, but only about 50% of patients achieve good outcome after endovascular therap…
Sponsor: General Hospital of Shenyang Military Region • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New vaccine shows promise against Traveler's diarrhea in early trial
Vaccine CompletedThe study is designed to evaluate the safety, immunogenicity, and efficacy of the intramuscular administration of a CS6 based vaccine (CssBA) against ETEC co-administered with double mutant labile toxin (dmLT) in preventing moderate-severe diarrhea (MSD) following challenge with …
Phase 2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Vaccine
Last updated Jun 27, 2026 12:09 UTC
-
New depression pill shows promise in Late-Stage trial
Symptom relief Recruiting nowThe study will evaluate the efficacy of NBI-1065845 compared with placebo as an adjunctive treatment in participants with MDD on improving symptoms of depression.
Phase 3 • Sponsor: Neurocrine Biosciences • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
Immunotherapy plus chemo shows promise for esophageal cancer in early trial
Disease control Recruiting nowThis study is a prospective, observational clinical study. In this study, 30 patients with resectable locally advanced esophageal squamous carcinoma will be prospectively enrolled and treated with adebrelimab (SHR-1316) combined with nab-paclitaxel and cisplatin preoperatively an…
Phase 2 • Sponsor: Peking University Cancer Hospital & Institute • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New blood test aims to catch cancers early in veterans
Diagnosis Recruiting nowThe purpose of this research study is to evaluate the possible benefits of an investigational, but commercially available Galleri multi-cancer early detection (MCED) blood test which is designed to detect many types of cancer early in veterans who have served in the military in a…
Sponsor: Dana-Farber Cancer Institute • Aim: Diagnosis
Last updated Jun 27, 2026 09:08 UTC
-
New hope for lung cancer: drug cocktail trial launches
Disease control Recruiting nowResearchers are investigating new treatments for untreated advanced non-small cell lung cancer (NSCLC), which is the most common form of lung cancer and lung cancer that has spread beyond surgical removal. Standard treatments include immunotherapy, such as pembrolizumab, and chem…
Phase 2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
New hope for lung cancer patients when targeted drugs stop working
Disease control Recruiting nowThis study targets patients with advanced NSCLC driven with positive driver genes who have failed TKI treatment, enrolling 66-78 participants. Cohort1 :Patients will receive JS207 (10 or 15 mg/kg, IV, d1) + pemetrexed (500 mg/m², IV, d1) + platinum-based chemotherapy (carboplatin…
Phase 2 • Sponsor: Shanghai Junshi Bioscience Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Can a video call save a Child's life? emergency triage goes visual
Disease control CompletedDyspnoea is defined as the sensation of difficult or uncomfortable breathing experienced by a patient. It is a significant concern in emergency care, accounting for 8% of calls to the emergency medical call centre (EMCC) and 10% of Emergency department (ED) admissions. Among paed…
Sponsor: Poitiers University Hospital • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Can a gentle Head-Zap ease ADHD symptoms in kids?
Disease control CompletedThis project investigates the efficacy of transcranial electrical stimulation (tES) modalities, specifically transcranial direct current stimulation (tDCS) and transcranial alternating current stimulation (tACS), for treating Attention-Deficit/Hyperactivity Disorder (ADHD) in chi…
Sponsor: The National Brain Mapping Laboratory (NBML) • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Can AI and peer support close the opioid treatment gap?
Disease control Stopped earlyBlack and Latinx people who use opioids are disproportionately impacted by opioid overdose deaths. The proposed study assesses the efficacy of an open source, multimodal artificial intelligence-driven texting tool combined with peer recovery coach-supported text contact that deli…
Sponsor: Friends Research Institute, Inc. • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New dosing strategy aims to keep myeloma patients out of the hospital
Disease control Recruiting nowA phase II study of single agent elranatamab in patients with relapsed and/or refractory multiple myeloma (MM) who have previously received at least three classes of therapeutic agents and are refractory to the last line of treatment. The primary objective of this study is to imp…
Phase 2 • Sponsor: Ontario Clinical Oncology Group (OCOG) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New asthma drug could cut attacks for patients not helped by standard inhalers
Disease control Recruiting nowThis study evaluates the efficacy and safety of benralizumab as an add-on therapy in uncontrolled eosinophilic asthma participants treated with medium-dose ICS-LABA compared to the conventional treatment step of escalation of inhaled therapy to high-dose ICS-LABA.
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New drug combo shows promise in shrinking cervical tumors before surgery
Disease control OngoingThe goal of this clinical trial is to determine the effectiveness of the combination therapy of Eparbrutinib (QL1706) with neoadjuvant chemotherapy followed by Type I hysterectomy in treating locally advanced cervical cancer. Additionally, it will assess the safety profile of thi…
Phase 2 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New shot could shield against malaria for months
Prevention CompletedThis study will test a new drug (MAM01) to find which doses are safe and could help prevent people from getting malaria for at least 4 months. The study will take place in parts of Africa where malaria is common. Part A is an open-label study conducted in healthy adults whereas P…
Phase 1 • Sponsor: Gates Medical Research Institute • Aim: Prevention
Last updated Jun 27, 2026 13:00 UTC
-
Can a tailored program ease the toll of injuries on older adults living alone?
Symptom relief Recruiting nowTo examine the long-term effects of the Geriatric Trauma Care Program (GTCP) regarding pain, functional disability, depression, loneliness, and health-related quality of life among older adults with traumatic injuries who live alone.
Sponsor: Kaohsiung Medical University • Aim: Symptom relief
Last updated Aug 08, 2026 00:03 UTC
-
A tablet test aims to catch hidden attention and memory problems after stroke
Diagnosis CompletedStroke is one of the most common long-term disabilities in the world. Despite better access to more effective acute treatment, WHO reports a prediction of almost a doubling of disability-adjusted life-years (DALYs) in 2050. In UK about 100 000, in Sweden about 20,000 people suffe…
Sponsor: Umeå University • Aim: Diagnosis
Last updated Aug 15, 2026 00:00 UTC
-
Could the sound of your voice reveal depression?
Diagnosis CompletedA prospective, single arm, non-randomized, pivotal clinical validation study to evaluate the ability of the Kintsugi Voice Device (the Device) to aid clinical assessment for depression by comparing its output with a diagnosis made by a clinician using the Structured Clinical Inte…
Sponsor: Kintsugi Mindful Wellness, Inc. • Aim: Diagnosis
Last updated Aug 16, 2026 00:00 UTC
-
Could a vitamin B3 pill undo early heart damage from childhood adversity?
Disease control Recruiting nowAdverse childhood experiences (ACEs) are directly related to cardiovascular morbidity and mortality, and impaired vascular endothelial function (VEF) is an independent predictor of future cardiovascular disease (CVD) risk \[1, 2\]. Previous work from our lab (IRB 202010095) and o…
Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Squeeze away hypertension? handgrip device put to the test
Disease control Recruiting nowThe study will be a multi-center, randomized clinical trial to evaluate the safety and efficacy of using the Zona Plus handgrip therapy device compared to the use of an auditory relaxation therapy for treatment of high blood pressure and hypertension in subjects who are not curre…
Sponsor: Zona Health, Inc • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Engineered immune cells take on Hard-to-Treat pancreatic cancer
Disease control Recruiting nowThis is a single-arm, open-label clinical study to evaluate the safety, tolerability and preliminary efficacy of IX001 TCR-T injection in advanced pancreatic cancer patients with KRAS G12V mutation.
Phase 1 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC